Back to Search Start Over

Survival Outcomes in Patients (Pts) With Refractory or Relapsed and Refractory Multiple Myeloma (RRMM) in the MM 003 Trial: Impact of Stable Disease (SD) as a Response to Pomalidomide Plus Low-Dose Dexamethasone (POM+ LoDEX)

Authors :
Moreau, P Weisel, K Song, K Gibson, C Saunders, O Sternas, L Hong, K Zaki, M Dimopoulos, MA
Publication Year :
2015

Subjects

Subjects :
Health Sciences
Επιστήμες Υγείας

Details

Language :
English
Database :
OpenAIRE
Accession number :
edsair.dedup.wf.001..2233e53ec53400cd6fcfb5f1debb86d0

Tools

Authors Abstract Subjects Details